Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 289786
                    [Title] => Controlling blood pressure could save lives of diabetics
                    [Summary] => People with diabetes have to watch not only their blood sugar level but their blood pressure as well.


A number of large-scale studies have shown that having a blood pressure less than 130/80 mm Hg (millimeter of mercury) greatly reduces the risk of diabetes-related complications such as heart attack and stroke.


The Hypertension Optimal Treatment (HOT) trial published in the Lancet demonstrated that tight blood pressure control using a combination of antihypertension drugs felodipine and ramipril resulted in a fewer incidence of stroke and heart attack. 


                    [DatePublished] => 2005-08-04 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 255963
                    [Title] => Helping sustain hypertension treatment
                    [Summary] => With a fresh mandate coming from the people, the new administration is setting the example for an austere and simple lifestyle to gradually overcome the country’s economic woes.


Many businessmen are taking the cue and pledging to sacrifice their profitability to some extent through a "socially responsible pricing" of their products and services.


                    [DatePublished] => 2004-07-01 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 251588
                    [Title] => How post-election days worsen hypertension
                    [Summary] => Post-election days can worsen hypertension, figuratively and literally. 


Figuratively, just watching the candidates accusing each other of massive cheating only two days after people cast their votes is enough to make the blood pressure of people shot up. Conflicting claims on who is ahead on which surveys do not make the situation better.


These events have serious impact. The unstable political climate often gives rise to peso devaluation which triggers price increase on all commodities, medicines included.  


                    [DatePublished] => 2004-05-27 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 248982
                    [Title] => Affordable drug for hypertensive patients out
                    [Summary] => Patents have been regarded as a protection for manufacturers of pharmaceutical products. Some, however, regard them as a mechanism for monopoly and price exploitation such that even drugs used for life-saving indications may be given a premium pricing by their manufacturers, which may be beyond the financial reach of those who need them.


With the patent for the popularly prescribed antihypertensive felodipine already expired, thousands of hypertensive patients who are dependent on this drug can heave a sigh of relief with the introduction of an affordable brand of felodipine. 

                    [DatePublished] => 2004-05-06 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [4] => Array
                (
                    [ArticleID] => 247551
                    [Title] => Unilab files countersuit over patent issue
                    [Summary] => Leading Filipino pharmaceutical firm United Laboratories Inc. has filed a countersuit against multinational drug company AstraZeneca Pharmaceuticals (Phils.) Inc. in reaction to the latter’s allegation of patent infringement.


                    [DatePublished] => 2004-04-25 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

            [5] => Array
                (
                    [ArticleID] => 246269
                    [Title] => New felodipine for sustained BP treatment
                    [Summary] => A new brand of felodipine, a popularly prescribed antihypertensive drug, will soon be out in the market which is expected to address the problem of patient compliance because of its pharmacoeconomic or affordable cost. 


This will likely help sustain blood-pressure or BP control and prevent complications such as stroke and heart attack.


People suffering from chronic diseases such as hypertension, generally deal with a whole gamut of medical examinations and drug treatments to prolong life and hopefully, retard the progress of the disease. 


                    [DatePublished] => 2004-04-15 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

FELODIPINE

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 289786
                    [Title] => Controlling blood pressure could save lives of diabetics
                    [Summary] => People with diabetes have to watch not only their blood sugar level but their blood pressure as well.


A number of large-scale studies have shown that having a blood pressure less than 130/80 mm Hg (millimeter of mercury) greatly reduces the risk of diabetes-related complications such as heart attack and stroke.


The Hypertension Optimal Treatment (HOT) trial published in the Lancet demonstrated that tight blood pressure control using a combination of antihypertension drugs felodipine and ramipril resulted in a fewer incidence of stroke and heart attack. 


                    [DatePublished] => 2005-08-04 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 255963
                    [Title] => Helping sustain hypertension treatment
                    [Summary] => With a fresh mandate coming from the people, the new administration is setting the example for an austere and simple lifestyle to gradually overcome the country’s economic woes.


Many businessmen are taking the cue and pledging to sacrifice their profitability to some extent through a "socially responsible pricing" of their products and services.


                    [DatePublished] => 2004-07-01 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 251588
                    [Title] => How post-election days worsen hypertension
                    [Summary] => Post-election days can worsen hypertension, figuratively and literally. 


Figuratively, just watching the candidates accusing each other of massive cheating only two days after people cast their votes is enough to make the blood pressure of people shot up. Conflicting claims on who is ahead on which surveys do not make the situation better.


These events have serious impact. The unstable political climate often gives rise to peso devaluation which triggers price increase on all commodities, medicines included.  


                    [DatePublished] => 2004-05-27 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 248982
                    [Title] => Affordable drug for hypertensive patients out
                    [Summary] => Patents have been regarded as a protection for manufacturers of pharmaceutical products. Some, however, regard them as a mechanism for monopoly and price exploitation such that even drugs used for life-saving indications may be given a premium pricing by their manufacturers, which may be beyond the financial reach of those who need them.


With the patent for the popularly prescribed antihypertensive felodipine already expired, thousands of hypertensive patients who are dependent on this drug can heave a sigh of relief with the introduction of an affordable brand of felodipine. 

                    [DatePublished] => 2004-05-06 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [4] => Array
                (
                    [ArticleID] => 247551
                    [Title] => Unilab files countersuit over patent issue
                    [Summary] => Leading Filipino pharmaceutical firm United Laboratories Inc. has filed a countersuit against multinational drug company AstraZeneca Pharmaceuticals (Phils.) Inc. in reaction to the latter’s allegation of patent infringement.


                    [DatePublished] => 2004-04-25 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

            [5] => Array
                (
                    [ArticleID] => 246269
                    [Title] => New felodipine for sustained BP treatment
                    [Summary] => A new brand of felodipine, a popularly prescribed antihypertensive drug, will soon be out in the market which is expected to address the problem of patient compliance because of its pharmacoeconomic or affordable cost. 


This will likely help sustain blood-pressure or BP control and prevent complications such as stroke and heart attack.


People suffering from chronic diseases such as hypertension, generally deal with a whole gamut of medical examinations and drug treatments to prolong life and hopefully, retard the progress of the disease. 


                    [DatePublished] => 2004-04-15 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Controlling blood pressure could save lives of diabetics

August 4, 2005 - 12:00am

People with diabetes have to watch not only their blood sugar level but their blood pressure as well. A number of large-scale studies have shown that having a blood pressure less than 130/80 mm Hg (millimeter of...

Science and Environment

Helping sustain hypertension treatment

July 1, 2004 - 12:00am

With a fresh mandate coming from the people, the new administration is setting the example for an austere and simple lifestyle to gradually overcome the country’s economic woes. Many businessmen are taking...

Science and Environment

How post-election days worsen hypertension

May 27, 2004 - 12:00am

Post-election days can worsen hypertension, figuratively and literally. Figuratively, just watching the candidates accusing each other of massive cheating only two days after people cast their votes is enough to...

Science and Environment

Affordable drug for hypertensive patients out

May 6, 2004 - 12:00am

Patents have been regarded as a protection for manufacturers of pharmaceutical products. Some, however, regard them as a mechanism for monopoly and price exploitation such that even drugs used for life-saving indications...

Science and Environment

Unilab files countersuit over patent issue

April 25, 2004 - 12:00am

Leading Filipino pharmaceutical firm United Laboratories Inc. has filed a countersuit against multinational drug company AstraZeneca Pharmaceuticals (Phils.) Inc. in reaction to the latter’s allegation of patent...

Business

New felodipine for sustained BP treatment

April 15, 2004 - 12:00am

A new brand of felodipine, a popularly prescribed antihypertensive drug, will soon be out in the market which is expected to address the problem of patient compliance because of its pharmacoeconomic or affordable...

Science and Environment